Erythropoietin restores C-Fiber function and prevents pressure ulcer formation in diabetic mice

Journal of Investigative Dermatology

Volumn 131, Issue 11, 2011, Pages 2316-2322

  Demiot, Claire ^a,b   Sarrazy, Vincent ^a   Javellaud, James ^a   Gourloi, Loriane ^a   Botelle, Laurent ^a   Oudart, Nicole ^a   Achard, Jean Michel ^a  

^a UNIVERSITÉ DE LIMOGES   (France)

^b UNIVERSITY OF LIMOGES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DECUBITUS; DIABETES MELLITUS; DRUG EFFECT; ENDOTHELIUM; HISTOPATHOLOGY; MICROCIRCULATION; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; SKIN NERVE; STREPTOZOCIN DIABETES; TREATMENT DURATION; TREATMENT OUTCOME; VASODILATATION;

EID: 80054717738     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.211     Document Type: Article

References (32)

1. Anagnostou A, Liu Z, Steiner M et al. (1994) Erythropoietin receptor mRNA expression in human endothelial cells. Proc Natl Acad Sci USA 91:3974-8 (Pubitemid 24139555)
2. Beiswenger KK, Calcutt NA, Mizisin AP (2008) Epidermal nerve fiber quantification in the assessment of diabetic neuropathy. Acta Histochem 110:351-62
3. Beleslin-Cokic BB, Cokic VP, Yu X et al. (2004) Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells. Blood 104:2073-80 (Pubitemid 39297859)
4. Bianchi R, Buyukakilli B, Brines M et al. (2004) Erythropoietin both protects from and reverses experimental diabetic neuropathy. Proc Natl Acad Sci USA 101:823-8 (Pubitemid 38121042)
5. Buemi M, Galeano M, Sturiale A et al. (2004) Recombinant human erythropoietin stimulates angiogenesis and healing of ischemic skin wounds. Shock 22:169-73 (Pubitemid 40228196)
6. Chen ZY, Wang L, Asavaritkrai P et al. (2010) Up-regulation of erythropoietin receptor by nitric oxide mediates hypoxia preconditioning. J Neurosci Res 88:3180-8
7. Christianson JA, Riekhof JT, Wright DE (2003) Restorative effects of neurotrophin treatment on diabetes-induced cutaneous axon loss in mice. Exp Neurol 179:188-99 (Pubitemid 36279619)
8. Dalsgaard CJ, Rydh M, Haegerstrand A (1989) Cutaneous innervation in man visualized with protein gene product 9.5 (PGP 9.5) antibodies. Histochemistry 92:385-90
9. Demiot C, Tartas M, Fromy B et al. (2006) Aldose reductase pathway inhibition improved vascular and C-fiber functions, allowing for pressure-induced vasodilation restoration during severe diabetic neuropathy. Diabetes 55:1478-83 (Pubitemid 44195390)
10. Erbayraktar Z, Erbayraktar S, Yilmaz O et al. (2009) Nonerythropoietic tissue protective compounds are highly effective facilitators of wound healing. Mol Med 15:235-41
11. Ergur BU, Kiray M, Pekcetin C et al. (2008) Protective effect of erythropoietin pretreatment in testicular ischemia-reperfusion injury in rats. J Pediatr Surg 43:722-8 (Pubitemid 351474531)
12. Fromy B, Abraham P, Saumet JL (1998) Non-nociceptive capsaicin-sensitive nerve terminal stimulation allows for an original vasodilatory reflex in the human skin. Brain Res 811:166-8 (Pubitemid 29003379)
13. Fromy B, Abraham P, Saumet JL (2000a) Progressive calibrated pressure device to measure cutaneous blood flow changes to external pressure strain. Brain Res Brain Res Protoc 5:198-203 (Pubitemid 30210039)
14. Fromy B, Merzeau S, Abraham P et al. (2000b) Mechanisms of the cutaneous vasodilator response to local external pressure application in rats: Involvement of CGRP, neurokinins, prostaglandins and NO. Br J Pharmacol 131:1161-71
15. Galeano M, Altavilla D, Bitto A et al. (2006) Recombinant human erythropoietin improves angiogenesis and wound healing in experimental burn wounds. Crit Care Med 34:1139-46
16. Galeano M, Altavilla D, Cucinotta D et al. (2004) Recombinant human erythropoietin stimulates angiogenesis and wound healing in the genetically diabetic mouse. Diabetes 53:2509-17 (Pubitemid 39145612)
17. Hamed S, Ullmann Y, Egozi D et al. (2011) Fibronectin potentiates topical erythropoietin-induced wound repair in diabetic mice. J Invest Dermatol 131:1365-74
18. Hamed S, Ullmann Y, Masoud M et al. (2010) Topical erythropoietin promotes wound repair in diabetic rats. J Invest Dermatol 130:287-94
19. Hand CC, Brines M (2010) Promises and pitfalls in erythopoietin-mediated tissue protection: Are nonerythropoietic derivatives a way forward? J Invest Med; e-pub ahead of print 30 July 2010
20. Ishii Y, Sawada T, Murakami T et al. (2010) Renoprotective effect of erythropoietin against ischaemia-reperfusion injury in a non-human primate model. Nephrol Dial Transplant 26:1157-62
21. Koitka A, Abraham P, Bouhanick B et al. (2004) Impaired pressure-induced vasodilation at the foot in young adults with type 1 diabetes. Diabetes 53:721-5 (Pubitemid 38270642)
22. Leist M, Ghezzi P, Grasso G et al. (2004) Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305:239-42 (Pubitemid 38886736)
23. Rajamani K, Colman PG, Li LP et al. (2009) Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): A prespecified analysis of a randomised controlled trial. Lancet 373:1780-8
24. Sayan H, Ozacmak VH, Sen F et al. (2009) Pharmacological preconditioning with erythropoietin reduces ischemia-reperfusion injury in the small intestine of rats. Life Sci 84:364-71
25. Shen Y, Wang Y, Li D et al. (2010) Recombinant human erythropoietin pretreatment attenuates heart ischemia-reperfusion injury in rats by suppressing the systemic inflammatory response. Transplant Proc 42:1595-7
26. Solomon SD, Uno H, Lewis EF et al. (2010) Erythropoietic response and outcomes in kidney disease and type 2 diabetes. N Engl J Med 363:1146-55
27. Stadler I, Zhang RY, Oskoui P et al. (2004) Development of a simple, noninvasive, clinically relevant model of pressure ulcers in the mouse. J Invest Surg 17:221-7 (Pubitemid 39172992)
28. Tsuji S, Ichioka S, Sekiya N et al. (2005) Analysis of ischemia-reperfusion injury in a microcirculatory model of pressure ulcers. Wound Repair Regen 13:209-15 (Pubitemid 40489872)
29. Uehara K, Yamagishi S, Otsuki S et al. (2004) Effects of polyol pathway hyperactivity on protein kinase C activity, nociceptive peptide expression, and neuronal structure in dorsal root ganglia in diabetic mice. Diabetes 53:3239-47 (Pubitemid 39564501)
30. Urbancic-Rovan V (2005) Causes of diabetic foot lesions. Lancet 366:1675-6 (Pubitemid 41587435)
31. Vinik AI, Mehrabyan A (2004) Diabetic neuropathies. Med Clin N Am 88:947-99 (Pubitemid 39090347)
32. Wilkinson KD, Lee KM, Deshpande S et al. (1989) The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science 246:670-3 (Pubitemid 19283361)